Duodenal myotomy blocks reduction of meal size and prolongation of intermeal interval by cholecystokinin

Physiology and Behavior

Volumn 105, Issue 3, 2012, Pages 829-834

  Lateef, Dalya M ^a   Washington, Martha C ^a   Raboin, Shannon J ^a   Roberson, Allison E ^a   Mansour, Mahmoud M ^b   Williams, Carol S ^a   Sayegh, Ayman I ^a  

^a TUSKEGEE UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Cholecystokinin 1 receptor; Enteric nervous system; Intermeal interval; Meal size; Myotomy

Indexed keywords

CAMOSTAT; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; MESSENGER RNA; TRYPSIN INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENUM; FOOD INTAKE; GASTROINTESTINAL TRACT; MYOTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SPLANCHNIC NERVE; VAGUS NERVE;

ANALYSIS OF VARIANCE; ANIMALS; AUTONOMIC DENERVATION; CHOLECYSTOKININ; DUODENUM; EATING; FEEDING BEHAVIOR; GABEXATE; GENE EXPRESSION REGULATION; MALE; MUSCLE DENERVATION; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RNA, MESSENGER; SINCALIDE; TIME FACTORS;

EID: 81355147146     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.10.018     Document Type: Article

References (64)

1. Buchan A.M., Polak J.M., Solcia E., Capella C., Hudson D., Pearse A.G. Electron immunohistochemical evidence for the human intestinal I cell as the source of CCK. Gut 1978, 19:403-407.
2. Buffa R., Solcia E., Go V.L. Immunohistochemical identification of the cholecystokinin cell in the intestinal mucosa. Gastroenterology 1976, 70:528-532.
3. Larsson L.I., Rehfeld J.F. Distribution of gastrin and CCK cells in the rat gastrointestinal tract. Evidence for the occurrence of three distinct cell types storing COOH-terminal gastrin immunoreactivity. Histochemistry 1978, 58:23-31.
4. Gibbs J., Young R.C., Smith G.P. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973, 84:488-495.
5. Lateef DM, Washington MC, Sayegh AI. The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval. Peptides.
6. Melville L.D., Smith G.P., Gibbs J. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats. Pharmacol Biochem Behav 1992, 43:975-977.
7. Sullivan C.N., Raboin S.J., Gulley S., Sinzobahamvya N.T., Green G.M., Reeve J.R., et al. Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1071-R1080.
8. Smith G.P., Jerome C., Cushin B.J., Eterno R., Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981, 213:1036-1037.
9. South E.H., Ritter R.C. Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety. Peptides 1988, 9:601-612.
10. Brown TA, Washington MC, Metcalf SA, Sayegh AI. The feeding responses evoked by cholecystokinin are mediated by vagus and splanchnic nerves. Peptides.
11. Cox J.E., Kelm G.R., Meller S.T., Randich A. Suppression of food intake by GI fatty acid infusions: roles of celiac vagal afferents and cholecystokinin. Physiol Behav 2004, 82:27-33.
12. Le Sauter J., Goldberg B., Geary N. CCK inhibits real and sham feeding in gastric vagotomized rats. Physiol Behav 1988, 44:527-534.
13. Debas H.T., Konturek S.J., Grossman M.I. Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. Am J Physiol 1975, 228:1172-1177.
14. Le Sauter J., Geary N. Redundant vagal mediation of the synergistic satiety effect of pancreatic glucagon and cholecystokinin in sham feeding rats. J Auton Nerv Syst 1990, 30:13-22.
15. Weatherford S.C., Ritter S. Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake. Physiol Behav 1988, 43:645-650.
16. Altschuler S.M., Bao X.M., Bieger D., Hopkins D.A., Miselis R.R. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts. J Comp Neurol 1989, 283:248-268.
17. Altschuler S.M., Escardo J., Lynn R.B., Miselis R.R. The central organization of the vagus nerve innervating the colon of the rat. Gastroenterology 1993, 104:502-509.
18. Berthoud H.R., Blackshaw L.A., Brookes S.J., Grundy D. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 2004, 16(Suppl 1):28-33.
19. Gulley S., Sharma S.K., Mansour M., Sullivan C.N., Moran T.H., Sayegh A.I. Strain differences in myenteric neuron number and CCK(1) receptor mRNA expression may account for differences in CCK induced c-Fos activation. Brain Res 2005, 1058:109-119.
20. Monstein H.J., Nylander A.G., Salehi A., Chen D., Lundquist I., Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand J Gastroenterol 1996, 31:383-390.
21. Sternini C., Wong H., Pham T., De Giorgio R., Miller L.J., Kuntz S.M., et al. Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine. Gastroenterology 1999, 117:1136-1146.
22. Washington MC, Murry CR, Raboin SJ, Roberson AE, Mansour MM, Williams CS, Sayegh AI. Cholecystokinin-8 activates myenteric neurons in 21- and 35-day old but not 4- and 14-day old rats. Peptides;32:272-80.
23. Cox J.E. Cholecystokinin satiety involves CCKA receptors perfused by the superior pancreaticoduodenal artery. Am J Physiol 1998, 274:R1390-R1396.
24. Cox J.E., Perdue G.S., Tyler W.J. Suppression of sucrose intake by continuous near-celiac and intravenous cholecystokinin infusions in rats. Am J Physiol 1995, 268:R150-R155.
25. Smith G.P., Falasco J., Moran T.H., Joyner K.M., Gibbs J. CCK-8 decreases food intake and gastric emptying after pylorectomy or pyloroplasty. Am J Physiol 1988, 255:R113-R116.
26. Smith G.T., Moran T.H., Coyle J.T., Kuhar M.J., O'Donahue T.L., McHugh P.R. Anatomic localization of cholecystokinin receptors to the pyloric sphincter. Am J Physiol 1984, 246:R127-R130.
27. Cox J.E., McCown S.M., Bridges J.M., Tyler W.J. Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions. Am J Physiol 1996, 270:R319-R325.
28. Reeve J.R., Green G.M., Chew P., Eysselein V.E., Keire D.A. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am J Physiol Gastrointest Liver Physiol 2003, 285:G255-G265.
29. Yamamoto M., Reeve J.R., Keire D.A., Green G.M. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. Am J Physiol Gastrointest Liver Physiol 2005, 288:G866-G879.
30. Overduin J., Reeve J.R.J., Strohmayer A.J., Gibbs J. atiating actions of peripheral CCK-8 and CCK-58 have similar durations. Society for Neuroscience 2000, 1531.
31. Raboin S.J., Reeve J.R., Green G.M., Cox J.E., Gibbs J., Perez L.J., et al. Differential effects of exogenous CCK-8 and CCK-58 on food intake. Appetite 2007, 49:322.
32. Raboin S.J., Reeve J.R., Cooper M.S., Green G.M., Sayegh A.I. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat. Regul Pept 2008, 150:73-80.
33. Larsen CJ, Washington MC, Sayegh AI. Cholecystokinin-8 increases the satiety ratio in diabetic rats more than cholecystokinin-33. Physiol Behav;101:649-52.
34. Metcalf SA, Washington MC, Brown TA, Williams CS, Strader AD, Sayegh AI. Ileal interposition attenuates the satiety responses evoked by cholecystokinin-8 and -33. Peptides.
35. Washington MC, Coggeshall J, Sayegh AI. Cholecystokinin-33 Inhibits Meal Size and Prolongs the Subsequent Intermeal Interval. Peptides.
36. Voigt J.P., Wenz D., Voits M., Fink H. Does increased endogenous CCK interact with serotonin to reduce food intake in rats?. Peptides 2000, 21:1895-1901.
37. Washington MC, Wright SA, Sayegh AI. Gastrin releasing peptide-29 evokes feeding responses in the rat. Peptides;32:241-5.
38. Furness J.B., Costa M. Projections of intestinal neurons showing immunoreactivity for vasoactive intestinal polypeptide are consistent with these neurons being the enteric inhibitory neurons. Neurosci Lett 1979, 15:199-204.
39. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034.
40. Berthoud H.R., Kressel M., Raybould H.E., Neuhuber W.L. Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol (Berl) 1995, 191:203-212.
41. Berthoud H.R., Patterson L.M., Neumann F., Neuhuber W.L. Distribution and structure of vagal afferent intraganglionic laminar endings (IGLEs) in the rat gastrointestinal tract. Anat Embryol (Berl) 1997, 195:183-191.
42. Phillips R.J., Powley T.L. As the gut ages: timetables for aging of innervation vary by organ in the Fischer 344 rat. J Comp Neurol 2001, 434:358-377.
43. Powley T.L., Chi M.M., Baronowsky E.A., Phillips R.J. Gastrointestinal tract innervation of the mouse: afferent regeneration and meal patterning after vagotomy. Am J Physiol Regul Integr Comp Physiol 2005, 289:R563-R574.
44. Calingasan N., Ritter S., Ritter R., Brenner L. Low-dose near-celiac arterial cholecystokinin suppresses food intake in rats. Am J Physiol 1992, 263:R572-R577.
45. Cox J.E. Inhibitory effects of cholecystokinin develop through interaction with duodenal signals. Behav Brain Res 1990, 38:35-44.
46. Cox J.E. Duodenal sucrose and glucose infusions enhance suppression by cholecystokinin of sham feeding. Am J Physiol 1994, 266:R466-R471.
47. Schwartz G.J., Moran T.H. CCK elicits and modulates vagal afferent activity arising from gastric and duodenal sites. Ann N Y Acad Sci 1994, 713:121-128.
48. Schwartz G.J., Tougas G., Moran T.H. Integration of vagal afferent responses to duodenal loads and exogenous CCK in rats. Peptides 1995, 16:707-711.
49. Cooper M.S., Reeve J.R., Abdalla M.O., Moyer L., Raboin S.J., Green G.M., et al. Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complex. Brain Res 2008, 1205:27-35.
50. Cooper M.S., Reeve J.R., Raboin S.J., Abdalla M.O., Green G.M., Sayegh A.I. Cholecystokinin-58 and cholecystokinin-8 produce similar but not identical activations of myenteric plexus and dorsal vagal complex. Regul Pept 2008, 148:88-94.
51. Gulley S., Covasa M., Ritter R.C., Sayegh A.I. Cholecystokinin1 receptors mediate the increase in Fos-like immunoreactivity in the rat myenteric plexus following intestinal oleate infusion. Physiol Behav 2005, 86:128-135.
52. Sayegh A.I., Covasa M., Ritter R.C. Intestinal infusions of oleate and glucose activate distinct enteric neurons in the rat. Auton Neurosci 2004, 115:54-63.
53. Sayegh A.I., Mansour M.M., Reddy G.P. Cholecystokinin selectively activates small but not large intestinal enteric neurons in the rat. FASEB J 2002, 16:A1248.
54. 1 receptors. Auton Neurosci 2007, 135:66.
55. Sayegh A.I., Ritter R.C. CCK-A receptor activation induces fos expression in myenteric neurons of rat small intestine. Regul Pept 2000, 88:75-81.
56. Sayegh A.I., Ritter R.C. Cholecystokinin activates specific enteric neurons in the rat small intestine. Peptides 2003, 24:237-244.
57. Ismair M.G., Stieger B., Cattori V., Hagenbuch B., Fried M., Meier P.J., et al. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology 2001, 121:1185-1190.
58. Gores G.J., LaRusso N.F., Miller L.J. Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am J Physiol 1986, 250:G344-G349.
59. Gores G.J., Kost L.J., Miller L.J., LaRusso N.F. Processing of cholecystokinin by isolated liver cells. Am J Physiol 1989, 257:G242-G248.
60. Keire D.A., Solomon T.E., Reeve J.R. NMR evidence for different conformations of the bioactive region of rat CCK-8 and CCK-58. Biochem Biophys Res Commun 2002, 293:1014-1020.
61. Reeve J.R., Rosenquist G.L., Keire D.A., Chew P., Nicholas H.B., Davis M.T., et al. Crucial role of position 40 for interactions of CCK-58 revealed by sequence of cat CCK-58. Biochem Biophys Res Commun 2006, 348:819-825.
62. Webb T., Gulley S., Esdaile A.R., Pruitt F., Sharma S.K., Williams C.S., et al. Effects of cholecystokinin-receptor antagonists on Fos-like immunoreactivity stimulated by sulfated cholecystokinin-8 in neurons of the myenteric plexus and hindbrain of rats. Am J Vet Res 2005, 66:1308-1313.
63. Berthoud H.R., Patterson L.M. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat (Basel) 1996, 156:123-131.
64. Patterson L.M., Zheng H., Ward S.M., Berthoud H.R. Immunohistochemical identification of cholecystokinin A receptors on interstitial cells of Cajal, smooth muscle, and enteric neurons in rat pylorus. Cell Tissue Res 2001, 305:11-23.